Carregant...
SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularisation in a rat model of Retinopathy of Prematurity
PURPOSE: We tested the hypothesis that recombinant human VEGF-A(165)b and the serine arginine protein kinase (SRPK) inhibitor, SRPIN340, which controls splicing of the VEGF-A pre-mRNA, prevent neovascularisation in a rodent model of retinopathy of prematurity (ROP). METHODS: In the 50/10 oxygen-indu...
Guardat en:
| Publicat a: | Invest Ophthalmol Vis Sci |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6485497/ https://ncbi.nlm.nih.gov/pubmed/23761094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.13-11634 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|